Tpg Gp A, LLC Rallybio Corp Call Options Transaction History
Tpg Gp A, LLC
- $1.66 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding RLYB
# of Institutions
49Shares Held
31.6MCall Options Held
0Put Options Held
0-
Viking Global Investors LP4.19MShares$2.35 Million0.0% of portfolio
-
Johnson & Johnson New Brunswick, NJ3.64MShares$2.04 Million0.42% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA3.63MShares$2.03 Million0.83% of portfolio
-
New Leaf Venture Partners, L.L.C. New York, NY3.3MShares$1.85 Million3.34% of portfolio
-
Pivotal Bio Venture Partners Investment Advisor LLC San Francisco, CA2.4MShares$1.35 Million0.77% of portfolio
About Rallybio Corp
- Ticker RLYB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,132,000
- Market Cap $18M
- Description
- Rallybio Corporation, a clinical-stage biotechnology company, engages in discovering, developing, manufacturing, and delivering therapies that enhance the lives of patients suffering from severe and rare diseases. Its lead product candidate is RLYB212, a monoclonal anti-HPA-1a antibody that is in Phase I clinical trial for the prevention of feta...